Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12EGE | ISIN: US6993743029 | Ticker-Symbol: N/A
Frankfurt
20.09.23
21:50 Uhr
2,024 Euro
0,000
0,00 %
1-Jahres-Chart  (nicht börsennotiert)
PARATEK PHARMACEUTICALS INC Chart 1 Jahr

Aktuelle News zur PARATEK

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.10.23Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 202314
02.10.23Paratek Pharmaceuticals, Inc. - 15-12G, Securities registration termination10
21.09.23XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.09.2023647The following instruments on Boerse Frankfurt do have their last trading day on 21.09.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.09.2023ISIN NameLU0908501215 LYXOR...
► Artikel lesen
21.09.23Novo Holdings advances antimicrobial resistance strategy with acquisition of Paratek Pharmaceuticals475Paratek's successful commercialization platform to advance novel therapies developed organically and through acquisitionsParatek adds 'final-mile' capabilities to AMR effortsCOPENHAGEN, Denmark...
► Artikel lesen
21.09.23Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.373CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital ("Gurnet Point") and Novo Holdings A/S ("Novo Holdings") announced today the completion of their acquisition of Paratek Pharmaceuticals...
► Artikel lesen
21.09.23XFRA N4CN: AUSSETZUNG/SUSPENSION233DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPARATEK PHARMAC....
► Artikel lesen
18.09.23Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and Novo Holdings A/S383BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ("Paratek") (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of...
► Artikel lesen
04.08.23XFRA N4CN: WIEDERAUFNAHME/RESUMPTION511FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
02.08.23Paratek Pharmaceuticals Files Definitive Proxy Statement and Letter to Stockholders in Connection with Acquisition by Gurnet Point Capital and Novo Holdings272Transaction Provides Paratek Stockholders with Immediate Value and Liquidity Stockholders to Receive Upfront Cash Payment of $2.15 per Share and a Contingent Value Right of $0.85 per Share on Achievement...
► Artikel lesen
27.06.23Paratek Pharmaceuticals Acknowledges Receipt of NexPoint Letter352BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ("Paratek") (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of...
► Artikel lesen
27.06.23Paratek Pharmaceuticals: European Medicines Agency COMP Recommends Positive Opinion on Orphan Medicinal Product Designation for NUZYRA (omadacycline) for Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease215BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving...
► Artikel lesen
06.06.23XFRA N4CN: AUSSETZUNG/SUSPENSION327DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPARATEK PHARMAC....
► Artikel lesen
06.06.23Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings978Transaction Provides Paratek Shareholders with Immediate Value and Liquidity Reflects Potential Value of $3.00 per Share of Common Stock, Including Upfront Cash Payment of $2.15 per Share and a Contingent...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten